Featured Research

from universities, journals, and other organizations

Silicon Medicines May Be Effective In Humans

Date:
February 1, 2007
Source:
University of Wisconsin-Madison
Summary:
As carbon-based life forms, humans and other animals, invariably, are treated for disease with the help of carbon-based medicines. But now, in a promising new study, scientists have shown that silicon - the stuff of computer chips, glass and pottery - may have extraordinary therapeutic value for treating human disease.

As carbon-based life forms, humans and other animals, invariably, are treated for disease with the help of carbon-based medicines.

Related Articles


But now, in a promising new study, scientists have shown that silicon - the stuff of computer chips, glass and pottery - may have extraordinary therapeutic value for treating human disease.

"All medicines are carbon-based - like we are," says Robert West, a University of Wisconsin-Madison chemist and one of the world's leading authorities on silicon chemistry. "There are about 50,000 biologically active molecules, and they're all mainly carbon-based."

But now, West and his colleagues report in the January edition of the journal Silicon Chemistry that the effectiveness and safety of an important anti-inflammatory and anti-cancer drug were enhanced remarkably by replacing one of the molecule's carbon atoms with a silicon atom.

The drug, indomethacin, is used to treat arthritis and some cancers, but the drug is little used because it is quite toxic.

"Our thought was, maybe we could tame it," says West, a UW-Madison professor of chemistry.

The idea, according to West and colleague Galina Bikzhanova, was to make a simple chemical change to see if the biological properties of the drug could be modified to be safer and more effective. By trading one of the drug's carbon atoms for a silicon atom and exposing the modified agent to cancer cells in culture, West's group found that the molecule's effectiveness was enhanced and its toxicity greatly reduced.

Indomethacin is an anti-inflammatory drug belonging to a family of compounds known as COX inhibitors. COX inhibitors selectively block an enzyme that causes pain and swelling.

"Our molecule is a COX-2 inhibitor like Tylenol and Vioxx and other such drugs," notes West.

How the drug and other COX inhibitors work against cancer is not well understood, but they clearly demonstrate anti-cancer properties, according to West. The modified molecule with the silicon atom was exposed to several types of cancer cells in culture in the new study. The agent had significant effects on skin and prostate cancer cells, but showed the greatest efficacy against pancreatic cancer cells.

"The results are very promising, especially in using our compound in combination with standard anticancer drugs," says West, who conducted the study in collaboration with Bikzhanova, Irina Toulokhonova of UW-Madison and Stephen Gately of RND Pharmaceuticals in Scottsdale, Ariz.

Tested on cancer cells in cultures, the modified drug both slowed the growth of cancer cells and killed cancer cells directly. The high activity was against pancreatic cancer cells. This is important because pancreatic cancer responds poorly to any therapy and is almost always fatal because it is hard to detect and spreads rapidly.

Perhaps just as important, the silicon-modified molecule exhibited far less toxicity than the all-carbon-based form of the drug.

"We tested for toxicity and it is well tolerated," West explains. "That's really different than indomethacin and the other indomethacin derivatives that have been made."

West and his colleagues made four variants of the drug, each with a slightly different chemical structure but all containing the silicon atom.

Why does silicon have this effect?

"It changes the property of the molecule, but not drastically," the Wisconsin chemist explains.

"It's fine tuning," says Bikzhanova. "We don't know why, but it led to this unexpectedly strong effect against cancer cells."


Story Source:

The above story is based on materials provided by University of Wisconsin-Madison. Note: Materials may be edited for content and length.


Cite This Page:

University of Wisconsin-Madison. "Silicon Medicines May Be Effective In Humans." ScienceDaily. ScienceDaily, 1 February 2007. <www.sciencedaily.com/releases/2007/01/070131211839.htm>.
University of Wisconsin-Madison. (2007, February 1). Silicon Medicines May Be Effective In Humans. ScienceDaily. Retrieved December 19, 2014 from www.sciencedaily.com/releases/2007/01/070131211839.htm
University of Wisconsin-Madison. "Silicon Medicines May Be Effective In Humans." ScienceDaily. www.sciencedaily.com/releases/2007/01/070131211839.htm (accessed December 19, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, December 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Kids Die While Under Protective Services

Kids Die While Under Protective Services

AP (Dec. 18, 2014) As part of a six-month investigation of child maltreatment deaths, the AP found that hundreds of deaths from horrific abuse and neglect could have been prevented. AP's Haven Daley reports. (Dec. 18) Video provided by AP
Powered by NewsLook.com
Dads-To-Be Also Experience Hormone Changes During Pregnancy

Dads-To-Be Also Experience Hormone Changes During Pregnancy

Newsy (Dec. 18, 2014) A study from University of Michigan researchers found that expectant fathers see a decrease in testosterone as the baby's birth draws near. Video provided by Newsy
Powered by NewsLook.com
Prenatal Exposure To Pollution Might Increase Autism Risk

Prenatal Exposure To Pollution Might Increase Autism Risk

Newsy (Dec. 18, 2014) Harvard researchers found children whose mothers were exposed to high pollution levels in the third trimester were twice as likely to develop autism. Video provided by Newsy
Powered by NewsLook.com
UN: Up to One Million Facing Hunger in Ebola-Hit Countries

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

AFP (Dec. 17, 2014) Border closures, quarantines and crop losses in West African nations battling the Ebola virus could lead to as many as one million people going hungry, UN food agencies said on Wednesday. Duration: 00:52 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins